Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2007-10-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.2007.078360PMID 17934098PMCID PMC2095293
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of Treatment Strategies in Early Rheumatoid Arthritis: A Randomized Trial

  2008cited by this paper
• Assessing remission in clinical practice.

  2007cited by this paper
• Effects of glucocorticoids on radiological progression in rheumatoid arthritis.

  2007cited by this paper
• Comparison of Treatment Strategies in Early Rheumatoid Arthritis

  2007cited by this paper
• Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)

  2007cited by this paper
• Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis.

  2007cited by this paper
• Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study

  2006cited by this paper
• Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.

  2006cited by this paper
• Are Glucocorticoids DMARDs?

  2006cited by this paper
• How should best strategy and tight control be translated into clinical practice? Comment on the article by Goekoop-Ruiterman et al.

  2006cited by this paper
• EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

  2006cited by this paper
• ACR remission criteria and response criteria.

  2006cited by this paper
• Definitions of remission for rheumatoid arthritis and review of selected clinical cohorts and randomised clinical trials for the rate of remission.

  2006cited by this paper
• Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.

  2006cited by this paper
• Treating very early rheumatoid arthritis.

  2006cited by this paper
• What should be our treatment goal in rheumatoid arthritis today?

  2006cited by this paper
• Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remission

  2005cited by this paper
• Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial

  2005cited by this paper
• The consequences of rheumatoid arthritis: quality of life measures in the individual patient.

  2005cited by this paper
• Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

  2005cited by this paper
• Therapeutic strategies in early rheumatoid arthritis.

  2005cited by this paper
• Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission.

  2004cited by this paper
• Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.

  2004cited by this paper
• Balanced polymorphism selected by genetic versus infectious human disease.

  2003cited by this paper
• Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: implications for disease pathogenesis.

  2003cited by this paper
• Understanding the window of opportunity concept in early rheumatoid arthritis.

  2003cited by this paper
• The epidemiology of malaria in Papua New Guinea.

  2003cited by this paper
• COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention.

  2002cited by this paper
• HLA associations in P. falciparum malaria patients from Mumbai, western India.

  2002cited by this paper
• Consensus recommendations for the assessment and treatment of rheumatoid arthritis.

  2001cited by this paper
• Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS.

  2001cited by this paper
• Management of rheumatoid arthritis: the historical context.

  2001cited by this paper
• Genetic variability, molecular evolution, and geographic diversity of HLA-B27.

  2001cited by this paper
• Remission and response to early treatment of RA assessed by the Disease Activity Score. BARFOT study group. Better Anti-rheumatic Farmacotherapy.

  2000cited by this paper
• Outcome of patients with early rheumatoid arthritis over a two year period

  1999cited by this paper
• Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group.

  1999cited by this paper
• The original "DAS" and the "DAS28" are not interchangeable: comment on the articles by Prevoo et al.

  1998cited by this paper
• Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with “sawtooth” strategy

  1998cited by this paper
• Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria.

  1996cited by this paper
• The Effectiveness of Early Treatment with Second-Line Antirheumatic Drugs

  1996cited by this paper
• Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

  1995cited by this paper
• Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

  1994cited by this paper
• Development of a disease activity score based on judgment in clinical practice by rheumatologists.

  1993cited by this paper
• Development of a disease activity score based on judgment in clinical practice by rheumatologists.

  1993cited by this paper
• Remodeling the pyramid--a concept whose time has come.

  1989cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Long-term outcome of treating rheumatoid arthritis: results after 20 years.

  1987cited by this paper
• The treatment of rheumatoid arthritis.

  1949cited by this paper
• Treatment of rheumatoid arthritis

  1949cited by this paper

• Immunadsorption bei rheumatischen Autoimmunerkrankungen: eine alternative Therapieoption

  2025cites this paper
• Structural and Functional Outcomes in Rheumatoid Arthritis After 10-Year Therapy with Disease-Modifying Antirheumatic Drugs Under Tight Control: Evidence from Real-World Cohort Data

  2025cites this paper
• Optical spectral transmission to monitor disease activity in arthritis patients: longitudinal follow-up comparison with clinical parameters.

  2025cites this paper
• CXCL13 as a Predictive Biomarker for Response to Methotrexate Monotherapy in Rheumatoid Arthritis

  2025cites this paper
• Evaluation of diagnostic and therapeutic delay in patients with rheumatoid arthritis and psoriatic arthritis.

  2024cites this paper
• Subtle Radiographic Progression at Six Months Can Be Detected Using Automated Quantitative Software in Rheumatoid Arthritis While Receiving Tocilizumab.

  2024cites this paper
• Structured and prompt treatment of early arthritis in clinical practice leverages window of opportunity and leads to excellent clinical outcomes: an innovative retrospective cohort study

  2024cites this paper
• Barriers to, Facilitators of, and Interventions to Support Treat‐to‐Target Implementation in Rheumatoid Arthritis: A Systematic Review

  2024cites this paper
• Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis

  2023cites this paper
• Joining telehealth in rheumatology: a survey on the role played by personalized experience from patients’ perspective

  2023cites this paper
• Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

  2022cites this paper
• Treatment of rheumatoid arthritis and its outcomes in an aging society: a single-center cohort study in Japan from 2011 to 2020

  2022cites this paper
• Ultraschallgezielte Gelenkpunktion in der Rheumatologie

  2022cites this paper
• Automatic Carpal Site Detection Method for Evaluation of Rheumatoid Arthritis Using Deep Learning

  2022cites this paper
• Utility of the HandScan in monitoring disease activity and prediction of clinical response in rheumatoid arthritis patients: an explorative study

  2021cites this paper
• Nurse‐Led Consultation for Patients With Rheumatoid Arthritis at Low Disease Activity: A Randomized Noninferiority Trial

  2021cites this paper
• Application of Automated Hand Ultrasound Scanning and a Simplified Three-Joint Scoring System for Assessment of Rheumatoid Arthritis Activity.

  2021cites this paper
• Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years

  2021cites this paper
• Treat-to-Target Strategies in Rheumatoid Arthritis: a Systematic Review and Cost-Effectiveness Analysis

  2021cites this paper
• Response to: ‘Comment on ‘Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab’’ by Pethoe-Schramm et al

  2020cites this paper
• The multi-biomarker disease activity test for assessing response to treatment strategies using methotrexate with or without prednisone in the CAMERA-II trial

  2020cites this paper
• Diagnostic Value of Optical Spectral Transmission in Rheumatoid Arthritis: Associations with Clinical Characteristics and Comparison with Joint Ultrasonography

  2020cites this paper
• Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?

  2020cites this paper
• Saga of the Rheumatoid Arthritis Activity Criteria

  2020cites this paper
• Fully automatic quantitative software for assessment of minute finger joint space narrowing progression on radiographs: evaluation in rheumatoid arthritis patients with long-term sustained clinical low disease activity

  2020cites this paper
• Insights into the treatment of rheumatoid arthritis: A paradigm in medicine.

  2020cites this paper
• Evaluation of Response Criteria in Rheumatoid Arthritis Treated With Biologic Disease‐Modifying Antirheumatic Drugs

  2020cites this paper
• Cost‐Effectiveness of Combination Disease‐Modifying Antirheumatic Drugs Versus Tumor Necrosis Factor Inhibitors in Active Rheumatoid Arthritis: A Pragmatic, Randomized, Multicenter Trial

  2020cites this paper
• Measuring inflammation in rheumatoid arthritis with a new clinical and ultrasound index: development and initial validation

  2019cites this paper
• Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort

  2019cites this paper
• Novel optical spectral transmission (OST)-guided versus conventionally disease activity-guided treatment: study protocol of a randomized clinical trial on guidance of a treat-to-target strategy for early rheumatoid arthritis

  2019cites this paper
• Detection of Fine Radiographic Progression in Finger Joint Space Narrowing Beyond Human Eyes: Phantom Experiment and Clinical Study with Rheumatoid Arthritis Patients

  2019cites this paper
• Does Triple Conventional Synthetic Disease-Modifying Antirheumatic Drug Therapy Improve upon Methotrexate as the Initial Treatment of Choice for a Rheumatoid Arthritis Patient?

  2019cites this paper
• Unmet needs in the treatment of rheumatoid arthritis. An observational study and a real-life experience from a single university center.

  2019cites this paper
• Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes

  2019cites this paper
• Cost-effectiveness of combination disease-modifying antirheumatics vs. necrosis inhibitors in

  2019cites this paper
• Rheumatoid arthritis

  2018cites this paper
• Targeting IL-6: A review of data

  2018cites this paper
• Imaging and Methotrexate Response Monitoring of Systemic Inflammation in Arthritic Rats Employing the Macrophage PET Tracer [18F]Fluoro-PEG-Folate

  2018cites this paper
• Early non-response to certolizumab pegol in rheumatoid arthritis predicts treatment failure at one year. Data from a randomised phase III clinical trial.

  2018cites this paper
• New therapeutic strategies in systemic lupus erythematosus management

  2018cites this paper
• Novel Experimental Therapeutic and PET Imaging of Activated Macrophages in Rheumatoid Arthritis

  2018cites this paper
• Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohorts.

  2018cites this paper
• Планирование регистрационной программы исследований препаратов базисной противовоспалительной терапии ревматоидного артрита

  2018cites this paper
• Use of the Orem self-care model on pain relief in women with rheumatoid arthritis: a randomized trial

  2018cites this paper
• Discovery of circulating DMARD response biomarkers in rheumatoid arthritis

  2018cites this paper
• Poly-γ-glutamic acid suppresses osteoclastogenesis in human osteoclast precursors and prevents joint damage in a collagen-induced murine arthritis model.

  2018cites this paper
• OFIL VOL 27-1-2017_MaquetaciÛn 1

  2017cites this paper
• Diagnosis and early management of inflammatory arthritis

  2017cites this paper
• Effects of antirheumatic drug underutilization on rheumatoid arthritis disease activity

  2017cites this paper
• Use of Biologics and Biosimilars in Rheumatology.

  2017cites this paper
• Impact of ultrasonography on treatment decision in rheumatoid arthritis: the IMPULSAR study

  2017cites this paper
• Change Over Time in the Pattern of Clinical Response to First-line Biologic Drugs in Patients with Rheumatoid Arthritis: Observational Data in a Real-life Setting

  2017cites this paper
• Musculoskeletal Loads during Stationary Cycling and the Effects of Pedal Modifications for Knee Osteoarthritis

  2017cites this paper
• Setting Drugs in Patients with Rheumatoid Arthritis : Observational Data in a Real-life Change Over Time in the Pattern of Clinical Response to First-line Biologic

  2017cites this paper
• The effects of B cell depletion on bone turnover in rheumatoid arthritis

  2017influential citation
• Automatic Quantification of Radiographic Wrist Joint Space Width of Patients With Rheumatoid Arthritis

  2017cites this paper
• The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis.

  2017cites this paper
• Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial

  2016cites this paper
• Determining the Lowest Optimally Effective Methotrexate Dose for Individual RA Patients Using Their Dose Response Relation in a Tight Control Treatment Approach

  2016cites this paper
• Patient-initiated appointments compared with standard outpatient care for rheumatoid arthritis: a randomised controlled trial

  2016influential citation
• Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease

  2016cites this paper
• Does disease activity add to functional disability in estimation of utility for rheumatoid arthritis patients on biologic treatment?

  2016cites this paper
• Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

  2016cites this paper
• Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment

  2016cites this paper
• Treat-to-target as an approach in inflammatory arthritis

  2016cites this paper
• The Computer Assisted Management in Early Rheumatoid Arthritis programme tool used in the CAMERA-I and CAMERA-II studies.

  2016cites this paper
• Automatic Quantification of Radiographic Finger Joint Space Width of Patients With Early Rheumatoid Arthritis

  2016cites this paper
• Quality of care in rheumatology. Translating evidence into practice

  2016cites this paper
• Rheumatoid cachexia in rheumatoid arthritis patients treated in the current treat-to-target era : an exploration of the incidence, mechanisms, effects on physical function, and a potential nutritional treatment

  2016influential citation
• The influence of patient perceptions of disease on medication intensification in daily practice.

  2016cites this paper
• Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry

  2016cites this paper
• Quality in rheumatoid arthritis care.

  2015cites this paper
• Severe low back pain in patients with rheumatoid arthritis is associated with Disease Activity Score but not with radiological findings on plain X-rays

  2015cites this paper
• Sustained Macrophage Infiltration upon Multiple Intra-Articular Injections: An Improved Rat Model of Rheumatoid Arthritis for PET Guided Therapy Evaluation

  2015cites this paper
• Laboratory diagnostics of systemic autoimmune diseases – Update 2013

  2015cites this paper
• Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update

  2015cites this paper
• Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype–positive rheumatoid arthritis patients

  2015cites this paper
• Computerised versus conventional methodology of radiographic joint destruction assessment in early rheumatoid arthritis

  2015cites this paper
• Tight control of rheumatoid arthritis in a resource-constrained setting: a randomized controlled study comparing the clinical disease activity index and simplified disease activity index.

  2015cites this paper
• Combination conventional DMARDs compared to biologicals: what is the evidence?

  2015cites this paper
• Current and future trends in biomarker discovery and development of companion diagnostics for arthritis

  2015cites this paper
• Alternative Ways to Quantify Sustained Remission: Applying the Continuity Rewarded Score and Patient Vector Graph

  2015cites this paper
• Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges

  2015cites this paper
• A multi-biomarker disease activity score tracks clinical response consistently in patients with rheumatoid arthritis treated with different anti-tumor necrosis factor therapies: A retrospective observational study

  2015cites this paper
• Introduction of a metabolic joint asymmetry score derived from conventional bone scintigraphy

  2015cites this paper
• Why do Hong Kong patients need total hip arthroplasty? An analysis of 512 hips from 1998 to 2010.

  2015cites this paper
• Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

  2015cites this paper
• S100A8/A9 as a biomarker for synovial inflammation and joint damage in patients with rheumatoid arthritis

  2014cites this paper
• Labordiagnostik systemischer Autoimmunerkrankungen: Update 2013

  2014cites this paper
• Rheumatoid Arthritis: Aiming for Cure - Commitment to Care

  2014cites this paper
• Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviews.

  2014cites this paper
• The separate impact of tight control schemes and disease activity on quality of life in patients with early rheumatoid arthritis: results from the CAMERA trials.

  2014cites this paper
• Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World

  2014cites this paper
• Scores for all seasons: SDAI and CDAI.

  2014cites this paper
• Measuring disease activity in early rheumatoid arthritis: An emerging challenge

  2014cites this paper
• Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment

  2014cites this paper
• Dose optimization of infliximab in patients with rheumatoid arthritis

  2014cites this paper
• Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.

  2014cites this paper
• Создание и применение диагностического индекса, основанного на многопараметрическом анализе биомаркеров, для определения активности ревматоидного артрита

  2014cites this paper